rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
1994-11-4
|
pubmed:abstractText |
To evaluate (1) the effect of granulocyte colony-stimulating factor (G-CSF) on peripheral-blood stem-cell (PBSC) mobilization; (2) the rate of hematopoietic recovery after G-CSF-mobilized PBSC transplantation; and (3) the outcome of high-dose myeloablative therapy and PBSC transplantation in patients with relapsed or refractory lymphoma.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0732-183X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
2176-86
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7523609-Adolescent,
pubmed-meshheading:7523609-Adult,
pubmed-meshheading:7523609-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7523609-Carmustine,
pubmed-meshheading:7523609-Cell Movement,
pubmed-meshheading:7523609-Cohort Studies,
pubmed-meshheading:7523609-Combined Modality Therapy,
pubmed-meshheading:7523609-Cyclophosphamide,
pubmed-meshheading:7523609-Etoposide,
pubmed-meshheading:7523609-Female,
pubmed-meshheading:7523609-Follow-Up Studies,
pubmed-meshheading:7523609-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:7523609-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:7523609-Hematopoietic Stem Cells,
pubmed-meshheading:7523609-Hodgkin Disease,
pubmed-meshheading:7523609-Humans,
pubmed-meshheading:7523609-Leukocyte Count,
pubmed-meshheading:7523609-Lymphoma, Non-Hodgkin,
pubmed-meshheading:7523609-Male,
pubmed-meshheading:7523609-Middle Aged,
pubmed-meshheading:7523609-Multivariate Analysis,
pubmed-meshheading:7523609-Platelet Count,
pubmed-meshheading:7523609-Prognosis,
pubmed-meshheading:7523609-Transplantation, Autologous,
pubmed-meshheading:7523609-Whole-Body Irradiation
|
pubmed:year |
1994
|
pubmed:articleTitle |
High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
|
pubmed:affiliation |
Department of Hematology/Bone Marrow Transplantation, City of Hope National Medical Center, Duarte, CA 91010.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.
|